compound introduction
Nadecnemab is an IgG4κ antibody targeting to GFRA3 , glial cell derived neurotrophic factor family receptor alpha 3 . Nadecnemab can be used for research of osteoarthritis of the knee/pain. Appearance:Liquid IC50& Target:Glial cell derived neurotrophic factor family receptor alpha 3 (GFRA3) Biological Activity:Nadecnemab is an IgG4κ antibody targeting to GFRA3 , glial cell derived neurotrophic factor family receptor alpha 3 . Nadecnemab can be used for research of osteoarthritis of the knee/pain.
